nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—endothelium—acquired immunodeficiency syndrome	0.0577	0.14	CbGeAlD
Tirofiban—ITGA2B—blood plasma—acquired immunodeficiency syndrome	0.0512	0.124	CbGeAlD
Tirofiban—ITGB3—endothelium—acquired immunodeficiency syndrome	0.0504	0.122	CbGeAlD
Tirofiban—ITGB3—blood plasma—acquired immunodeficiency syndrome	0.0448	0.108	CbGeAlD
Tirofiban—ITGB3—skin of body—acquired immunodeficiency syndrome	0.0215	0.0521	CbGeAlD
Tirofiban—ITGA2B—lymphoid tissue—acquired immunodeficiency syndrome	0.0199	0.0483	CbGeAlD
Tirofiban—ITGA2B—blood—acquired immunodeficiency syndrome	0.0188	0.0454	CbGeAlD
Tirofiban—ITGA2B—bone marrow—acquired immunodeficiency syndrome	0.0182	0.044	CbGeAlD
Tirofiban—ITGB3—lymphoid tissue—acquired immunodeficiency syndrome	0.0174	0.0422	CbGeAlD
Tirofiban—ITGB3—digestive system—acquired immunodeficiency syndrome	0.0172	0.0417	CbGeAlD
Tirofiban—ITGA2B—lung—acquired immunodeficiency syndrome	0.0165	0.0398	CbGeAlD
Tirofiban—ITGB3—blood—acquired immunodeficiency syndrome	0.0164	0.0397	CbGeAlD
Tirofiban—ITGB3—bone marrow—acquired immunodeficiency syndrome	0.0159	0.0384	CbGeAlD
Tirofiban—ITGB3—lung—acquired immunodeficiency syndrome	0.0144	0.0348	CbGeAlD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.0127	0.0809	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—CXCR4—acquired immunodeficiency syndrome	0.0126	0.0802	CbGpPWpGaD
Tirofiban—ITGA2B—brain—acquired immunodeficiency syndrome	0.0116	0.0282	CbGeAlD
Tirofiban—ITGA2B—lymph node—acquired immunodeficiency syndrome	0.0113	0.0272	CbGeAlD
Tirofiban—Haemorrhage intracranial—Saquinavir—acquired immunodeficiency syndrome	0.0111	0.0258	CcSEcCtD
Tirofiban—Haemoglobin decreased—Nelfinavir—acquired immunodeficiency syndrome	0.0102	0.0238	CcSEcCtD
Tirofiban—Haemoglobin decreased—Stavudine—acquired immunodeficiency syndrome	0.0102	0.0237	CcSEcCtD
Tirofiban—ITGB3—lymph node—acquired immunodeficiency syndrome	0.00984	0.0238	CbGeAlD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00981	0.0623	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—CXCR4—acquired immunodeficiency syndrome	0.00973	0.0618	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—CSF2—acquired immunodeficiency syndrome	0.00946	0.0601	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Amprenavir—acquired immunodeficiency syndrome	0.00935	0.0218	CcSEcCtD
Tirofiban—Haemoglobin decreased—Indinavir—acquired immunodeficiency syndrome	0.00822	0.0191	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Nevirapine—acquired immunodeficiency syndrome	0.00766	0.0178	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Stavudine—acquired immunodeficiency syndrome	0.0074	0.0172	CcSEcCtD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—CSF2—acquired immunodeficiency syndrome	0.00729	0.0463	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Abacavir—acquired immunodeficiency syndrome	0.00729	0.017	CcSEcCtD
Tirofiban—Haemoglobin decreased—Saquinavir—acquired immunodeficiency syndrome	0.00661	0.0154	CcSEcCtD
Tirofiban—Haemoptysis—Saquinavir—acquired immunodeficiency syndrome	0.00615	0.0143	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.00599	0.038	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Indinavir—acquired immunodeficiency syndrome	0.00598	0.0139	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Efavirenz—acquired immunodeficiency syndrome	0.00565	0.0132	CcSEcCtD
Tirofiban—ITGB3—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	0.00519	0.033	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	0.00519	0.033	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.00505	0.0321	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Ritonavir—acquired immunodeficiency syndrome	0.005	0.0116	CcSEcCtD
Tirofiban—Myocardial infarction—Amprenavir—acquired immunodeficiency syndrome	0.00485	0.0113	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Saquinavir—acquired immunodeficiency syndrome	0.00481	0.0112	CcSEcCtD
Tirofiban—Swelling—Indinavir—acquired immunodeficiency syndrome	0.00465	0.0108	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.00462	0.0293	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Lamivudine—acquired immunodeficiency syndrome	0.00459	0.0107	CcSEcCtD
Tirofiban—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.00421	0.0098	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.00391	0.0248	CbGpPWpGaD
Tirofiban—Myocardial infarction—Abacavir—acquired immunodeficiency syndrome	0.00378	0.0088	CcSEcCtD
Tirofiban—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00376	0.00877	CcSEcCtD
Tirofiban—Sweating—Stavudine—acquired immunodeficiency syndrome	0.00375	0.00874	CcSEcCtD
Tirofiban—Haematuria—Stavudine—acquired immunodeficiency syndrome	0.00373	0.00869	CcSEcCtD
Tirofiban—Chills—Didanosine—acquired immunodeficiency syndrome	0.00363	0.00846	CcSEcCtD
Tirofiban—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.00354	0.00825	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—ALB—acquired immunodeficiency syndrome	0.00354	0.0225	CbGpPWpGaD
Tirofiban—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00352	0.00821	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	0.00337	0.0214	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.00335	0.0213	CbGpPWpGaD
Tirofiban—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.00326	0.0076	CcSEcCtD
Tirofiban—Haematuria—Zidovudine—acquired immunodeficiency syndrome	0.00324	0.00755	CcSEcCtD
Tirofiban—Chills—Stavudine—acquired immunodeficiency syndrome	0.00315	0.00734	CcSEcCtD
Tirofiban—Chills—Abacavir—acquired immunodeficiency syndrome	0.00311	0.00723	CcSEcCtD
Tirofiban—Myocardial infarction—Indinavir—acquired immunodeficiency syndrome	0.0031	0.00722	CcSEcCtD
Tirofiban—Sweating—Indinavir—acquired immunodeficiency syndrome	0.00303	0.00706	CcSEcCtD
Tirofiban—Haematuria—Indinavir—acquired immunodeficiency syndrome	0.00302	0.00703	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.00301	0.0191	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL6—acquired immunodeficiency syndrome	0.00294	0.0187	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00288	0.0067	CcSEcCtD
Tirofiban—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.00287	0.00667	CcSEcCtD
Tirofiban—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00285	0.00665	CcSEcCtD
Tirofiban—Haematuria—Efavirenz—acquired immunodeficiency syndrome	0.00285	0.00664	CcSEcCtD
Tirofiban—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00284	0.00661	CcSEcCtD
Tirofiban—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00282	0.00656	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.00279	0.0177	CbGpPWpGaD
Tirofiban—Chills—Zidovudine—acquired immunodeficiency syndrome	0.00274	0.00638	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—ALB—acquired immunodeficiency syndrome	0.00273	0.0173	CbGpPWpGaD
Tirofiban—Haematuria—Delavirdine—acquired immunodeficiency syndrome	0.00273	0.00635	CcSEcCtD
Tirofiban—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00261	0.00609	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	0.0026	0.0165	CbGpPWpGaD
Tirofiban—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.00259	0.00604	CcSEcCtD
Tirofiban—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00259	0.00602	CcSEcCtD
Tirofiban—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00259	0.00602	CcSEcCtD
Tirofiban—Chills—Indinavir—acquired immunodeficiency syndrome	0.00255	0.00593	CcSEcCtD
Tirofiban—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00254	0.00591	CcSEcCtD
Tirofiban—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00253	0.0059	CcSEcCtD
Tirofiban—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.00252	0.00587	CcSEcCtD
Tirofiban—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.0025	0.00583	CcSEcCtD
Tirofiban—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00246	0.00573	CcSEcCtD
Tirofiban—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00246	0.00573	CcSEcCtD
Tirofiban—Pain—Didanosine—acquired immunodeficiency syndrome	0.00246	0.00573	CcSEcCtD
Tirofiban—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00245	0.00571	CcSEcCtD
Tirofiban—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00244	0.00569	CcSEcCtD
Tirofiban—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00242	0.00564	CcSEcCtD
Tirofiban—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00241	0.00562	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.00241	0.0153	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00241	0.00561	CcSEcCtD
Tirofiban—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00239	0.00556	CcSEcCtD
Tirofiban—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00237	0.00553	CcSEcCtD
Tirofiban—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00233	0.00542	CcSEcCtD
Tirofiban—Chills—Delavirdine—acquired immunodeficiency syndrome	0.0023	0.00537	CcSEcCtD
Tirofiban—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.0023	0.00535	CcSEcCtD
Tirofiban—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00229	0.00532	CcSEcCtD
Tirofiban—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00227	0.00529	CcSEcCtD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL6—acquired immunodeficiency syndrome	0.00226	0.0144	CbGpPWpGaD
Tirofiban—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00221	0.00515	CcSEcCtD
Tirofiban—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00217	0.00505	CcSEcCtD
Tirofiban—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00217	0.00505	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.00215	0.0136	CbGpPWpGaD
Tirofiban—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00214	0.00499	CcSEcCtD
Tirofiban—Pain—Stavudine—acquired immunodeficiency syndrome	0.00213	0.00497	CcSEcCtD
Tirofiban—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00213	0.00496	CcSEcCtD
Tirofiban—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00212	0.00495	CcSEcCtD
Tirofiban—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00212	0.00493	CcSEcCtD
Tirofiban—Pain—Abacavir—acquired immunodeficiency syndrome	0.0021	0.0049	CcSEcCtD
Tirofiban—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.0021	0.00488	CcSEcCtD
Tirofiban—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00205	0.00478	CcSEcCtD
Tirofiban—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00205	0.00478	CcSEcCtD
Tirofiban—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00204	0.00476	CcSEcCtD
Tirofiban—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00202	0.0047	CcSEcCtD
Tirofiban—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00202	0.0047	CcSEcCtD
Tirofiban—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00202	0.0047	CcSEcCtD
Tirofiban—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00199	0.00463	CcSEcCtD
Tirofiban—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00198	0.00462	CcSEcCtD
Tirofiban—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00198	0.00461	CcSEcCtD
Tirofiban—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00198	0.0046	CcSEcCtD
Tirofiban—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00198	0.0046	CcSEcCtD
Tirofiban—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00197	0.0046	CcSEcCtD
Tirofiban—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.00456	CcSEcCtD
Tirofiban—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00195	0.00455	CcSEcCtD
Tirofiban—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00195	0.00454	CcSEcCtD
Tirofiban—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00194	0.00453	CcSEcCtD
Tirofiban—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00193	0.00449	CcSEcCtD
Tirofiban—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.0019	0.00444	CcSEcCtD
Tirofiban—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00187	0.00436	CcSEcCtD
Tirofiban—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00435	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.00186	0.0118	CbGpPWpGaD
Tirofiban—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00186	0.00432	CcSEcCtD
Tirofiban—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00184	0.0043	CcSEcCtD
Tirofiban—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00429	CcSEcCtD
Tirofiban—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00184	0.00428	CcSEcCtD
Tirofiban—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00182	0.00425	CcSEcCtD
Tirofiban—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00181	0.00422	CcSEcCtD
Tirofiban—Headache—Didanosine—acquired immunodeficiency syndrome	0.0018	0.0042	CcSEcCtD
Tirofiban—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.00416	CcSEcCtD
Tirofiban—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.00416	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00177	0.0112	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.00411	CcSEcCtD
Tirofiban—Pain—Indinavir—acquired immunodeficiency syndrome	0.00173	0.00402	CcSEcCtD
Tirofiban—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00401	CcSEcCtD
Tirofiban—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00172	0.004	CcSEcCtD
Tirofiban—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00399	CcSEcCtD
Tirofiban—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00171	0.00398	CcSEcCtD
Tirofiban—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00169	0.00393	CcSEcCtD
Tirofiban—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00166	0.00386	CcSEcCtD
Tirofiban—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.00385	CcSEcCtD
Tirofiban—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00165	0.00384	CcSEcCtD
Tirofiban—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.0038	CcSEcCtD
Tirofiban—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00163	0.0038	CcSEcCtD
Tirofiban—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00163	0.00379	CcSEcCtD
Tirofiban—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00162	0.00378	CcSEcCtD
Tirofiban—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00162	0.00377	CcSEcCtD
Tirofiban—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0016	0.00373	CcSEcCtD
Tirofiban—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.0016	0.00371	CcSEcCtD
Tirofiban—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.0037	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00159	0.0101	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00157	0.00998	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00157	0.00366	CcSEcCtD
Tirofiban—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00157	0.00365	CcSEcCtD
Tirofiban—Headache—Stavudine—acquired immunodeficiency syndrome	0.00156	0.00364	CcSEcCtD
Tirofiban—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00156	0.00363	CcSEcCtD
Tirofiban—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00155	0.00361	CcSEcCtD
Tirofiban—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00155	0.00361	CcSEcCtD
Tirofiban—Headache—Abacavir—acquired immunodeficiency syndrome	0.00154	0.00359	CcSEcCtD
Tirofiban—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00154	0.00358	CcSEcCtD
Tirofiban—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00353	CcSEcCtD
Tirofiban—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00353	CcSEcCtD
Tirofiban—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00351	CcSEcCtD
Tirofiban—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.0015	0.00349	CcSEcCtD
Tirofiban—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00149	0.00346	CcSEcCtD
Tirofiban—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00149	0.00346	CcSEcCtD
Tirofiban—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00148	0.00345	CcSEcCtD
Tirofiban—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00146	0.0034	CcSEcCtD
Tirofiban—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00145	0.00337	CcSEcCtD
Tirofiban—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00336	CcSEcCtD
Tirofiban—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00336	CcSEcCtD
Tirofiban—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00334	CcSEcCtD
Tirofiban—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.00327	CcSEcCtD
Tirofiban—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00323	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00136	0.00864	CbGpPWpGaD
Tirofiban—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00136	0.00317	CcSEcCtD
Tirofiban—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00313	CcSEcCtD
Tirofiban—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00312	CcSEcCtD
Tirofiban—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00311	CcSEcCtD
Tirofiban—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00311	CcSEcCtD
Tirofiban—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00308	CcSEcCtD
Tirofiban—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.003	CcSEcCtD
Tirofiban—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.003	CcSEcCtD
Tirofiban—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00299	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.00127	0.00809	CbGpPWpGaD
Tirofiban—Headache—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00294	CcSEcCtD
Tirofiban—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00294	CcSEcCtD
Tirofiban—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00289	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00124	0.00789	CbGpPWpGaD
Tirofiban—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00287	CcSEcCtD
Tirofiban—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00285	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00122	0.00777	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00121	0.00768	CbGpPWpGaD
Tirofiban—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00281	CcSEcCtD
Tirofiban—Nausea—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00279	CcSEcCtD
Tirofiban—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00279	CcSEcCtD
Tirofiban—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00278	CcSEcCtD
Tirofiban—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00266	CcSEcCtD
Tirofiban—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00266	CcSEcCtD
Tirofiban—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00264	CcSEcCtD
Tirofiban—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.0026	CcSEcCtD
Tirofiban—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00252	CcSEcCtD
Tirofiban—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.0025	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00107	0.0068	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00107	0.0068	CbGpPWpGaD
Tirofiban—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00246	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.00103	0.00654	CbGpPWpGaD
Tirofiban—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00239	CcSEcCtD
Tirofiban—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00237	CcSEcCtD
Tirofiban—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00233	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000981	0.00623	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000973	0.00618	CbGpPWpGaD
Tirofiban—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00097	0.00226	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000968	0.00615	CbGpPWpGaD
Tirofiban—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000964	0.00225	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000957	0.00608	CbGpPWpGaD
Tirofiban—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00092	0.00214	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000824	0.00523	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000824	0.00523	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	0.00081	0.00514	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000745	0.00473	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000661	0.0042	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000657	0.00417	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000624	0.00396	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000598	0.0038	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000562	0.00357	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000562	0.00357	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000551	0.0035	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000509	0.00323	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000506	0.00321	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000487	0.0031	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000461	0.00292	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000433	0.00275	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000433	0.00275	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000428	0.00272	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000425	0.0027	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000421	0.00268	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000393	0.0025	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000385	0.00245	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000376	0.00238	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000329	0.00209	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000324	0.00206	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000303	0.00192	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000297	0.00188	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000223	0.00141	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000171	0.00109	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000131	0.000831	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000101	0.00064	CbGpPWpGaD
